Stockreport

Jasper Therapeutics to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference

Jasper Therapeutics, Inc. - Class A  (JSPR) 
PDF REDWOOD CITY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic cell transplant ther [Read more]